Published in Trends Neurosci on August 01, 1994
Regeneration of diabetic axons is enhanced by selective knockdown of the PTEN gene. Brain (2014) 1.64
Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons. Brain (2009) 0.97
Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy. Am J Pathol (1999) 0.95
NGF promotes cell cycle progression by regulating D-type cyclins via PI3K/Akt and MAPK/Erk activation in human corneal epithelial cells. Mol Vis (2012) 0.91
Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model. Proc Natl Acad Sci U S A (2012) 0.83
Recombinant human nerve growth factor with a marked activity in vitro and in vivo. Proc Natl Acad Sci U S A (2005) 0.82
Gene therapy for the treatment of diabetic neuropathy. Curr Diab Rep (2008) 0.75
Neurotrophic factors in diabetic neuropathy. Trends Neurosci (1995) 0.75
Does rectal gonorrhoea reflect unsafe sex? Lancet (1991) 3.99
A flow-sensitive apparatus for studying the responses of the constrictor muscles of perfused tubular organs [proceedings]. J Physiol (1978) 2.14
Preventing the spread of HIV infection. BMJ (1991) 1.88
A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J (2001) 1.59
Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus. Diabetologia (1993) 1.44
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. Int J STD AIDS (1996) 1.38
The involvement of noradrenergic nerves in the cardiovascular reflex responses to lower body negative pressure in the anaesthetised rabbit. Pflugers Arch (1976) 1.29
Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia (1983) 1.21
A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats. Pain (1998) 1.20
Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes (1999) 1.16
Diabetes-induced alterations in calcium homeostasis in sensory neurones of streptozotocin-diabetic rats are restricted to lumbar ganglia and are prevented by neurotrophin-3. Diabetologia (2002) 1.10
Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurones. Brain Res (1993) 1.10
Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes (1997) 1.09
Aldose reductase inhibitors and their potential for the treatment of diabetic complications. Trends Pharmacol Sci (1994) 1.08
Further evidence for the involvement of microtubules in the intra-axonal movement of noradrenaline storage granules. J Physiol (1971) 1.03
Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil. Diabetes (1984) 1.03
Neurotrophin-3 prevents mitochondrial dysfunction in sensory neurons of streptozotocin-diabetic rats. Exp Neurol (2005) 1.03
Suppression of nerve growth factor-directed neurite outgrowth in PC12 cells by sphingosine, an inhibitor of protein kinase C. J Biol Chem (1988) 1.02
Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition. Diabetologia (1983) 1.00
Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation. Neuroscience (2005) 0.99
Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur J Neurosci (1995) 0.98
Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer's disease. J Neurochem (2002) 0.98
Xestospongin C empties the ER calcium store but does not inhibit InsP3-induced Ca2+ release in cultured dorsal root ganglia neurones. Cell Calcium (2002) 0.97
Hypoxic neuropathy: relevance to human diabetic neuropathy. Diabetologia (1990) 0.96
Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats. J Neuropathol Exp Neurol (1999) 0.95
Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia (1994) 0.94
A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia (1999) 0.94
Nerve growth factor modulates the activation status and fast axonal transport of ERK 1/2 in adult nociceptive neurones. Mol Cell Neurosci (2001) 0.93
Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy. Diabetologia (2001) 0.93
Chicken growth-associated protein GAP-43 is tightly bound to the actin-rich neuronal membrane skeleton. J Neurochem (1990) 0.92
Neutrophil sorbitol production impairs oxidative killing in diabetes. Diabet Med (1987) 0.91
Response and cosmetic outcome of two fractionation regimens for AIDS-related Kaposi's sarcoma. Radiother Oncol (1998) 0.91
Nerve growth factor- and neurotrophin-3-induced changes in nociceptive threshold and the release of substance P from the rat isolated spinal cord. J Neurosci (1997) 0.90
Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia (1995) 0.90
NMDA receptor activation modulates evoked release of substance P from rat spinal cord. Br J Pharmacol (1998) 0.90
Prosaposin: a myelinotrophic protein that promotes expression of myelin constituents and is secreted after nerve injury. Glia (1999) 0.89
Effects of treatment with myo-inositol or its 1,2,6-trisphosphate (PP56) on nerve conduction in streptozotocin-diabetes. Eur J Pharmacol (1993) 0.89
Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). J Peripher Nerv Syst (2014) 0.89
STI prevention and the male sex industry in London: evaluating a pilot peer education programme. Sex Transm Infect (2000) 0.88
Nerve growth factor treatment increases stimulus-evoked release of sensory neuropeptides in the rat spinal cord. Eur J Neurosci (1997) 0.88
Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Brain Res Mol Brain Res (1994) 0.88
Coexistence of nerve conduction deficit with increased Na(+)-K(+)-ATPase activity in galactose-fed mice. Implications for polyol pathway and diabetic neuropathy. Diabetes (1990) 0.88
Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats. J Peripher Nerv Syst (1999) 0.87
Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol. J Neurochem (1984) 0.87
Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia (1998) 0.87
Changes in preprotachykinin mRNA expression and substance P levels in dorsal root ganglia of monoarthritic rats: comparison with changes in synovial substance P levels. Brain Res (1995) 0.87
Independent learning packages (audio tape/pamphlet) for a course in cell excitation: evidence that they can be at least as effective as conventional lectures. Med Educ (1979) 0.87
Two populations or granular vesicles in constricted post-ganglionic sympathetic nerves. J Physiol (1975) 0.87
Altered neurotrophin mRNA levels in peripheral nerve and skeletal muscle of experimentally diabetic rats. J Neurochem (1995) 0.86
Interaction between fluconazole and rifampicin. BMJ (1990) 0.85
Neurotrophins and peripheral neuropathy. Philos Trans R Soc Lond B Biol Sci (1996) 0.85
Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor. Diabetes (1985) 0.85
Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats. Diabetes (1986) 0.85
Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor. J Neurol Sci (1989) 0.85
Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3. Brain (2003) 0.85
Proceedings: The noradrenaline concentration and the cholinesterase activity of the separated longitudinal and circular layers of muscle of the guinea-pig vas deferens. Br J Pharmacol (1974) 0.85
Neurotrophic factors in peripheral neuropathies: pharmacological strategies. Prog Neurobiol (1996) 0.85
Myelin/axonal pathology in interleukin-12 induced serial relapses of experimental allergic encephalomyelitis in the Lewis rat. Am J Pathol (2001) 0.85
Expression of axotomy-inducible and apoptosis-related genes in sensory nerves of rats with experimental diabetes. Brain Res Mol Brain Res (2004) 0.84
Axonal transport of activating transcription factor-2 is modulated by nerve growth factor in nociceptive neurons. J Neurosci (1999) 0.84
Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'. Diabetologia (1987) 0.84
Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition. Diabetologia (1988) 0.84
An analysis of the response of the perfused vas deferens of the rat to field stimulation [proceedings]. Br J Pharmacol (1978) 0.83
Enteric neuropeptides in streptozotocin-diabetic rats; effects of insulin and aldose reductase inhibition. J Auton Nerv Syst (1996) 0.83
Ganglioside treatment of streptozotocin-diabetic rats prevents defective axonal transport of 6-phosphofructokinase activity. J Neurochem (1988) 0.83
Insulin partially reverses deficits in peripheral nerve blood flow and conduction in experimental diabetes. J Neurol Sci (1996) 0.83
Autonomic neuropathy in the alloxan-diabetic rat. J Auton Pharmacol (1983) 0.83
Prostacyclin release in experimental diabetes: effects of evening primrose oil. Prostaglandins Leukot Essent Fatty Acids (1993) 0.82
Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus. Neurosci Lett (1982) 0.82
alpha-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support. Neurosci Lett (1997) 0.82
Management of mycoses associated with HIV disease. Int J STD AIDS (1996) 0.82
Targeted delivery of nerve growth factor via fibronectin conduits assists nerve regeneration in control and diabetic rats. Eur J Neurosci (1995) 0.82
The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na+/K+ pump in streptozotocin-diabetic rats. Br J Pharmacol (1992) 0.82
Pharmacological modulation of nerve growth factor synthesis: a mechanistic comparison of vitamin D receptor and beta(2)-adrenoceptor agonists. Brain Res Mol Brain Res (2000) 0.82
Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats. Diabetologia (1991) 0.82
Effect of streptozotocin-induced diabetes on NGF, P75(NTR) and TrkA content of prevertebral and paravertebral rat sympathetic ganglia. Brain Res (2000) 0.82
Reduced levels of mRNA encoding endoskeletal and growth-associated proteins in sensory ganglia in experimental diabetes. Diabetes (1995) 0.82
Does neuropathy develop in animal models? Clin Neurosci (1997) 0.82
Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor. Br J Pharmacol (1998) 0.81
Diabetes and axotomy-induced deficits in retrograde axonal transport of nerve growth factor correlate with decreased levels of p75LNTR protein in lumbar dorsal root ganglia. Brain Res Mol Brain Res (1997) 0.81
Effect of nerve growth factor treatment on p75NTR gene expression in lumbar dorsal root ganglia of streptozocin-induced diabetic rats. Diabetes (1998) 0.81
Elevated expression of neurotrophin-3 mRNA in sensory nerve of streptozotocin-diabetic rats. Neurosci Lett (1999) 0.81